High dose therapy and autologous stem cell transplant in older adults with multiple myeloma

Randomized trials showing that high dose therapy with autologous stem cell transplant (ASCT) improved overall survival in multiple myeloma (MM) excluded patients over age 65. To compare outcomes of older adults with MM who underwent ASCT with non-transplant strategies, we identified 146 patients age...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Bone Marrow Transplant
Hlavní autoři: Wildes, Tanya M, Finney, Joseph D, Fiala, Mark, Gao, Feng, Vij, Ravi, Stockerl-Goldstein, Keith, Carson, Kenneth R, Mikhael, Joseph, Colditz, Graham
Médium: Artigo
Jazyk:Inglês
Vydáno: 2015
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4526374/
https://ncbi.nlm.nih.gov/pubmed/25961765
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/bmt.2015.106
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky